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A B S T R A C T
Background: Established fracture nonunions rarely heal without secondary intervention. Revision
surgery is the most common intervention, though non-surgical options for nonunion would be useful if
they could overcome nonunion risk factors. Our hypothesis is that low-intensity pulsed ultrasound
(LIPUS) can enhance heal rate (HR) in fractures that remain nonunion after one year, relative to the
expected HR in the absence of treatment, which is expected to be negligible.
Methods: We collated outcomes from a prospective patient registry required by the U.S. Food & Drug
Administration. Patient data were collected over a 4-year period beginning in 1994 and were
individually reviewed and validated by a registered nurse. Patients were only included if they had four
data points available: date when fracture occurred; date when LIPUS treatment began; date when LIPUS
treatment ended; and a dichotomous outcome of healed vs. failed, assessed by clinical and radiological
criteria. Data were used to calculate two derived variables: days to treatment (DTT) with LIPUS, and days
on treatment (DOT) with LIPUS. Every validated chronic nonunion patient (DTT > 365 days) with
complete data is reported.
Results: Heal rate for chronic nonunion patients (N = 767) treated with LIPUS was 86.2%. Heal rate was
82.7% among 98 patients with chronic nonunion 5 years duration, and 12 patients healed after chronic
nonunion >10 years (HR = 63.2%). There was more patient loss to follow-up, non-compliance, and
withdrawal, comparing chronic nonunion patients to all other patients (p < 0.0001). Patient age was the
only factor associated with failure to heal among chronic nonunions (p < 0.004). Chronic nonunion
patients averaged 3.1 surgical procedures prior to LIPUS, but some LIPUS-treated patients were able to
heal without revision surgery. Among 91 patients who received LIPUS 90 days after their last surgery,
HR averaged 85.7%, and the time from last surgery to index use of LIPUS averaged 449.6 days.
Conclusions: Low-intensity pulsed ultrasound enhanced HR among fractures that had been nonunion for
at least 1 year, and even healed fractures that had been nonunion >10 years. LIPUS resulted in successful
healing in the majority of nonunions without further surgical intervention.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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example, one report concluded that 16% of patients with open
fracture develop delayed union or nonunion [5]. Though deﬁnitions
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Table 1
Summary of demographic data for 401 men (52.3% of the sample) and 348 women
(45.4% of the sample) in the cohort of patients with chronic nonunion; 18 patients
were of unknown gender. Mean ‘‘Smoking years’’ includes 296 patients (50%) who
never smoked.
Variable N= Mean SD
Age (years) 764 45.8 16.5
Days to treatment (DTT) 767 912.5 959.8
Days on treatment (DOT) 767 179.5 127.9
Weight (pounds) 619 174.4 44.7
Height (inches) 625 67.5 4.6
Body-mass index 616 26.7 5.6
Smoking years (mean) 593 7.0 11.9
R. Zura et al. / Injury, Int. J. Care Injured 46 (2015) 2036–2041 2037after fracture [6]. Patients diagnosed with nonunion are thought
to have a very low probability of healing without intervention, and
this value approaches zero for chronic nonunions [7].
Revision surgery is the most common intervention for
nonunion and it is usually successful [8]. In cases of gross bone
instability, broken hardware, or malalignment, there is no
acceptable alternative to surgery. However, revision procedures
can fail for many reasons [9], including advanced patient age [10],
comorbid conditions such as diabetes [11] or habitual use of
tobacco [12,13], frequent use of non-steroidal anti-inﬂammatory
(NSAID) medications [13], and perhaps even genetic predisposition
[14]. In short, patients may fail revision surgery for the same
reasons that they failed initial surgery. Surgical revision is also
technically difﬁcult [15] and carries risks inherent to any surgery.
Therefore, a non-surgical option for treating fracture nonunion
could be useful, especially if it was effective in the presence of risk
factors for surgical failure. Low-intensity pulsed ultrasound
(LIPUS) may be one such option [7,16].
We evaluated a large cohort of chronic nonunion patients
treated with LIPUS. The LIPUS system used (EXOGEN1, Bioventus,
LLC, Durham, N.C.) is a Class III non-invasive device approved by
the U.S. Food & Drug Administration (FDA) on the basis of
prospective clinical trials in healing of nonunions [7,16] and fresh
fractures [17,19]; subsequent trials also demonstrated clinical
efﬁcacy in delayed union [18].
A chronic nonunion is here deﬁned as a fracture that has failed
to heal for more than 12 months, using clinical and radiographic
criteria, at which time the nonunion diagnosis is not in doubt [6].
The study population was drawn from a validated, FDA-required
post-market registry of consecutive patients who used the Exogen
device, with data published in part previously [19–21]. Our
hypothesis is that low-intensity pulsed ultrasound (LIPUS) can
induce healing in chronic nonunion fractures.
Patients and methods
The present study was designed as a single arm, retrospective,
observational cohort study of a convenience sample of consecutive
consenting patients who had enrolled prospectively in a registry
for the Exogen device. Inclusion criteria were that patients be
males or non-pregnant females 18 years of age or older at
enrollment. Patients signed an informed consent at enrollment,
and were instructed to use the device for 20 continuous minutes
every day until healed.
This study was formally exempted from ethical approval by the
Institutional Review Board of the lead author’s institution [21]
because data were drawn from a post-market registry meant to
satisfy FDA reporting requirements. Heal rate (HR) in an acute-
fracture cohort of patients treated with LIPUS has been reported
[21], and we use similar methods here.
Registry data for the period from 14 Oct 1994 until 15 Oct
1998 were validated by a registered nurse who manually
compared every patient’s paper record to the digital record
[21]. To be analyzed, each patient was required to have four data
points [21]:
 Date of fracture: Calendar date when the fracture occurred
 Date LIPUS treatment started: Calendar date when LIPUS
treatment began
 Date LIPUS treatment ended: Calendar date when LIPUS
treatment ended
 Outcome: A dichotomous variable of healed/failed at treatment
end, as determined by the prescribing physician. For a fracture to
be healed, the registry protocol speciﬁed that a fracture had to
meet both clinical and radiological criteria: Clinically solid and free of pain on manual stress
 At least three of four cortices bridged on X-ray views
These data were used to calculate 2 derived variables of
interest [21]:
 Days-to-treatment (DTT): Time from fracture to LIPUS treatment
 Days-on-treatment (DOT): Time from LIPUS treatment until
treatment end
All patients with DTT, DOT, and outcome were analyzed if they
had chronic nonunion, deﬁned as DTT > 365 days. Patients with
DTT, DOT, and outcome have been reported for a cohort of 4190
patients with DTT < 90 days [21]. Some chronic nonunion data are
presented in comparison with cohorts having shorter DTT periods.
Patients who healed with LIPUS are also contrasted with patients
who did not heal.
The t-statistic (Satterthwaite method for unequal variances)
was used to compare means and the Fisher’s exact test and x2 test
were used to test for trend across fracture cohorts [21].
Conservatively, only p-values <0.01 were reported, since a large
sample size is prone to yield statistical signiﬁcance in the absence
of clinical signiﬁcance; using a smaller p-value threshold reduces
this risk. Ninety-ﬁve percent conﬁdence intervals (CIs) were
calculated for percent-healed point estimates. All data were
analyzed using SAS software, v9.3 (Cary, NC).
Results
A total of 7884 fractures in the registry had the 4 required data
elements [21]. These included 4190 acute fractures (90 days old
at the start of treatment), 2927 fractures characterized as delayed
union/nonunion (91–365 days old at the start of treatment), and
767 fractures that were chronic nonunions (DTT > 365 days old at
the start of treatment). The HR for all registry fractures (N = 7884)
was 93.9%, while the HR for chronic nonunion fractures (N = 767)
was 86.2%.
The average age for patients with a chronic nonunion was 45.8
years (Table 1). Neither height nor weight was outside the range of
normal, although body-mass index (BMI) suggests that these
patients were overweight.
Heal rate could not be calculated for chronic nonunion patients
whose records lacked outcome data, and these patients were not
included in the cohort of 767 chronic nonunion fractures. We
evaluated the excluded population to determine why the outcome
was missing and whether the missing data could potentially
distort the HR results. The number of chronic patients for whom
there was any record in the registry was N = 1286. The most cited
explanation for missing data was loss to follow-up (N = 207), with
fewer patients designated as non-compliant (N = 113), withdrawn
(N = 101), missing outcome (N = 85), deceased (N = 3) or other
(N = 10) (Fig. 1). Loss to follow-up, when contrasted with a
Fig. 1. Summary of the disposition of fractures in the Exogen registry database
expressed as a percentage of any record in the registry, for each cohort of patients.
Patients in the ‘‘Chronic nonunion’’ cohort (N = 1286, including all patients not
assessed as to outcome) are compared to patients in the ‘‘Fresh fracture’’ (N = 5765)
and the ‘‘Delayed union’’ (N = 4382) cohorts. This presentation shows that patients
in the chronic cohort of patients were substantially more likely to be non-compliant
or lost to follow-up, less likely to be retained in the registry, and more likely to fail in
response to treatment.
R. Zura et al. / Injury, Int. J. Care Injured 46 (2015) 2036–20412038combination of the other dispositions, was signiﬁcantly and
substantially different in the chronic cohort (p = 0.0008). Con-
versely, the proportion of patients who died or were otherwise
unaccounted for was comparable across all cohorts (Fig. 1).
We tested whether patients were systematically lost to follow-
up, potentially distorting results, by examining demographics ofTable 3
Comparison of chronic nonunion patients who healed with LIPUS to LIPUS-treated chron
that increase the risk of treatment failure, so we accept p < 0.01 as a minimum le
‘‘Medications’’, and ‘‘Smoking years’’ all include patients who reported zero values (e.g
Chronic nonunion cohort Healed N or % 
Patient age (years) 45.1 (16.5) 658 
Weight (lb) 173.6 (42.8) 534 
Height (in) 67.5 (4.7) 540 
Body-mass index 26.6 (5.3) 531 
Days-to-treatment (mean) 872.5 (866.9) 661 
Days-on-treatment (mean) 168.2 (113.6) 661 
Female (vs. male) (%)** 307 (vs. 354) 46.4% 
Open (vs. closed fracture) (%)** 100 (vs. 503) 16.6% 
Surgical procedures (mean) 3.1 (2.1) 331 
Comorbidities (mean) 1.4 (0.8) 143 
Medications (mean) 0.5 (0.8) 420 
Smoking years (mean) 6.8 (11.5) 510 
** p values shown are from t-tests, except comparisons with an asterisk, which were
Table 2
Comparison of chronic nonunion patients whose records include a healing outcome to th
in the tables that follow, to identify risk factors associated with failure to heal, so here
‘‘Smoking years’’ includes 296 patients (50%) who never smoked.
Entire registry sample Outcome (SD) N or % 
Patient age (years) 45.8 (16.5) 764 
Weight (lb) 174.4 (44.7) 619 
Height (in) 67.5 (4.6) 625 
Body-mass index 26.7 (5.6) 616 
Days-to-treatment (mean) 912.5 (959.8) 767 
Days-on-treatment (mean) 179.5 (127.9) 767 
Female (vs. male) (%)** 359 (vs. 408) 46.8% 
Open (vs. closed fracture) (%)** 111 (vs. 588) 15.9% 
Surgical procedures (mean) 3.1 (2.3) 388 
Comorbidities (mean) 1.4 (0.8) 165 
Medications (mean) 0.5 (0.7) 474 
Smoking years (mean) 7.0 (11.9) 593 
** p values are from t-tests, except comparisons with an asterisk, which were testedthe patients lacking outcome information (Table 2). Patients
lacking an outcome were on average 3.7 years younger
(p < 0.0001), male (p < 0.01), and stopped using LIPUS 39 days
sooner (p < 0.0001). Because these differences are not linked to
worse outcomes, it suggests that the heal rate data were not biased
in favour of healing by exclusion of patients with missing outcomes.
There were no signiﬁcant predictors of failure to heal in the
chronic cohort except age (Table 3). Mean body-mass index,
percent open fracture, number of comorbidities (e.g., cardiovascu-
lar disease, hypertension, vascular insufﬁciency, renal disease,
diabetes, alcoholism, arthritis, osteoporosis, and cancer), number
of medications, and number of smoking years – none of these
factors differed signiﬁcantly between healed and failed patients in
the chronic cohort. Even multiple prior surgical procedures did not
predispose a patient to fail LIPUS treatment; chronic nonunion
patients who healed averaged 3.1 surgical procedures prior to
healing. Patient age was signiﬁcant (p < 0.004), as was DOT
(p < 0.0001), presumably as a result of the failure to heal. Chronic
nonunions that healed did so in an average of 5.6 months, after
remaining unhealed for an average of 28.7 months prior to LIPUS
(Table 3).
For chronic nonunions treated with LIPUS, HR decreased with
increasing patient age (Fig. 2). However, the magnitude of this
decrease was modest. Compared with the overall HR of 86.2%, the
observed HR for patients aged 70–79 was 83.3% (40 of 48 fractures
healed). For patients 80 years or older, the observed HR was 77.8%
(14 of 18 fractures healed). A regression equation ﬁtted to these
data (HR = 96.2%  (0.2%*number of years)) can be used to predict
HR for patients of any age. According to this model, HR was only
12% lower for patients treated with LIPUS at age 80 (calculatedic patients who failed to heal. This approach should be very sensitive to risk factors
vel of signiﬁcance. Reported means for ‘‘Surgical procedures’’, ‘‘Comorbidities’’,
., no surgical procedures).
Failed N or % Signiﬁcance
50.0 (16.2) 106 0.004
179.8 (55.3) 85 NS
67.2 (4.0) 85 NS
27.6 (6.7) 85 NS
1161.1 (1387.0) 106 NS
250.1 (179.7) 106 <0.0001
52 (vs. 54) 49.1% NS
11 (vs. 85) 11.5% NS
3.2 (3.1) 57 NS
1.3 (0.6) 22 NS
0.6 (0.6) 54 NS
8.6 (14.1) 83 NS
 tested using Fischer’s exact test because they are dichotomous variables.
e records of chronic patients that lacked a healing outcome. This approach was used
 we test whether these risk factors are associated with lack of an outcome. Mean
No outcome (SD) N or % Signiﬁcance
42.1 (16.0) 518 <0.0001
179.5 (46.2) 370 NS
68.1 (6.2) 375 NS
27.3 (6.6) 368 NS
946.9 (1008.0) 519 NS
140.7 (115.6) 517 <0.0001
204 (vs. 314) 39.4% 0.01
86 (vs. 382) 18.4% NS
3.1 (2.5) 239 NS
1.4 (0.7) 99 NS
0.6 (0.8) 227 NS
8.8 (12.2) 355 NS
 using Fischer’s exact test because they are dichotomous variables.
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Heal Rate by Patient Age
Fig. 2. Summary of the effect of patient age on heal rate in the chronic cohort of
patients. Shown is the heal rate for each age category, with upper and lower 95%
conﬁdence intervals. A simple linear regression is also shown, with the 95%
conﬁdence interval for patient predicted values. The regression equation is:
HR = 96.2%  (0.2%*Year).
Table 4
Impact of bone fractured on heal rate (HR) in the chronic cohort. Every bone
represented in the database by more than 20 fractures is tabulated.
Bone Healed Failed HR (%) Lower
CI (%)
Upper
CI (%)
All fractures 661 106 86.2 83.7 88.6
All closed fractures 503 85 85.5 82.7 88.4
All open fractures 100 11 90.1 84.5 95.6
Tibia 168 21 88.9 84.4 93.4
Femur 129 24 84.3 78.6 90.1
Radius/Ulna 60 10 85.7 77.5 93.9
Humerus 52 13 80.0 70.3 89.7
Tibia/Fibula 50 6 89.3 81.2 97.4
Scaphoid 48 7 87.3 78.5 96.1
Ankle 35 6 85.4 74.5 96.2
Metatarsal 31 5 86.1 74.8 97.4
Foot 20 3 87.0 73.2 100.0
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HR = 92.2%).
Fracture HR was not signiﬁcantly impacted by how quickly
treatment started; we did not identify a point beyond which LIPUS
was ineffective (Fig. 3). The HR was 82.7% among 98 patients who
started LIPUS at least 5 years after fracture, and 12 of these patients
healed after chronic nonunion >10 years duration (HR = 63.2%).
Although the HR for patients with >10 year nonunions was lower
(as expected for such extreme cases), the overall difference in HR
was not signiﬁcant between fractures 1–2 years old (87.9%) and
fractures >3 years old (82.9%).
Different fractured bones had different HRs in the chronic
cohort (Table 4). Open fractures had a higher HR than closed
fractures, but this difference was not statistically signiﬁcant. Type
of surgical procedure performed prior to LIPUS had no signiﬁcant
impact on HR among chronic nonunion patients (Fig. 4). Use of
intermedullary nails did not result in signiﬁcantly decreased HR
relative to other forms of internal or external ﬁxation or to
conservative treatment.
Some chronic nonunions treated with LIPUS were able to heal
without revision surgery (Table 5). We characterized HR in chronic
nonunion patients for whom LIPUS treatment was given 90 days
after the last revision surgery, and for whom there was no
subsequent record of revision surgery after LIPUS treatment began.
Individual bones are reported if there were 10 patients in theFig. 3. Heal rate (HR) as a function of years to LIPUS treatment. There are no
signiﬁcant differences in HR as a function of years to treatment.category. Remaining bones were pooled into an ‘‘All other bones’’
category. Among 767 patients with chronic fracture, patients were
excluded because: there was an exclusionary surgical procedure
(e.g., pathological fracture) or a procedure lacked a treatment date
(N = 209); there was no record of surgery, but we were unable to
conﬁrm that surgery did not happen (N = 400); surgery was done
<90 days prior to LIPUS (N = 58); or there were apparent errors in
the database (N = 9). The nonunion HR from LIPUS in the absence of
surgery averaged 84.3% across the 4 bones reported, and 85.7%
across all 91 LIPUS-treated chronic fractures (Table 5). The time
interval between last revision surgery and index use of LIPUS
averaged 449.6 days among the 91 LIPUS-treated bones.
Discussion
The current cohort of 767 chronic nonunion patients treated
with LIPUS represents the largest chronic cohort reported to date.
In fractures that had not healed for at least one year, 86.2% ofFig. 4. Overall heal rate (HR) in the chronic cohort of patients was 86.2% (95%
conﬁdence interval: 83.7–88.6%). Procedures which were represented more than 20
times in the dataset are shown. Although ‘‘Bone graft’’ offers the highest overall HR,
most procedures offer comparable HR, among patients treated with LIPUS.
Table 5
Fracture heal rate (HR) among chronic nonunion patients with LIPUS treatment 90
days after the last revision surgery. This characterizes HR when chronic nonunion
patients are treated with LIPUS alone. ‘‘Days to LIPUS’’ is the average number of days
from the last surgical treatment to the time when LIPUS treatment began.
Bone # Prior
surgeries
Healed Failed HR (%) Days to
LIPUS
(average)
Tibia 1 7 0 100.0 –
2 4 3 57.1 –
3 9 2 81.8 –
Average 20 5 80.0 443.4
Tibia + Fibula 1 3 1 75.0 –
2 3 0 100.0 –
3 3 0 100.0 –
Average 9 1 90.0 464.8
Femur 1 5 3 62.5 –
2 1 0 100.0 –
3 11 0 100.0 –
Average 17 3 85.0 347.2
Humerus 1 4 0 100.0 –
2 5 0 100.0 –
3 4 2 66.7 –
Average 13 2 86.7 523.5
All other bones 1 12 2 85.7 –
2 2 0 100.0 –
3 5 0 100.0 –
Average 19 2 90.5 509.8
Overall average 78 13 85.7 449.6
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months at the start of LIPUS treatment, and patients had an average
of 3.1 prior attempts at surgical repair, yet the average time to heal
was 5.6 months with LIPUS (Table 3). Patient age in the chronic
cohort was correlated with HR; nevertheless, patients aged 70–79
and 80+ had an observed HR of 83.3% and 77.8%, respectively. A
linear regression of these data shows that the heal rate for an 80-
year-old was only 12% less than the HR for a 20-year-old (Fig. 2).
Type of surgical treatment received prior to LIPUS did not
signiﬁcantly impact HR (Fig. 4), and some LIPUS-treated patients
were able to heal chronic nonunions without revision surgery
(Table 5).
Compared with patients who received LIPUS for fresh fractures,
chronic nonunion patients were less likely to be compliant and less
likely to complete treatment (Fig. 1). The reasons for this are
unclear. However, patients lost to follow-up were younger and
more likely to be male (Table 2), and such factors have been
associated with lack of compliance in RCTs. Since neither age nor
gender was associated with lower HR, we do not believe that the
reported HR was biased by patients lost to follow-up.
Few risk factors emerged as correlates of treatment failure in
the chronic cohort (Table 3). Open fracture, BMI, number of prior
surgeries, and number of comorbidities did not differ signiﬁ-
cantly between healed and failed. One interpretation is that
these risk factors are not predictive of treatment-refractory
nonunion. An alternative explanation is that LIPUS treatment
mitigated these risk factors and lessened their role in nonunion
pathology. We cannot exclude either of these explanations with
the current data.
The HR of 86.2% we report is consistent with other reports of
LIPUS treatment for nonunion [7,16,22–27]. Nine previous studies of
LIPUS for nonunion have reported HRs ranging from 73% to 100%
[7,16,19,22–27], with a median HR of 86%. Our results are also
consistent with a systematic review of LIPUS for nonunions, which
reported an HR of 87% in 594 nonunions from 8 studies, with a mean
fracture age of 22.2 months and mean heal time of 4.8 months [28].The HR we observed in the current cohort is also within the
range of reported HRs for nonunion revision surgery. A review of 23
papers on surgical revision reported HRs between 68% and 96%,
with a mean of 86% [16]. Another group reviewed the literature on
exchange nailing for diaphyseal femur or tibia nonunions and
found HRs from 72% to 100% [29]. The same procedure in infected
nonunions and segmental bone defects yielded a HR of 85% [30].
Most recently, a single-centre prospective registry of 272
surgically revised nonunions reported a HR of 75% after the ﬁrst
surgery and 95% after two or more revision attempts [31].
Nonunion surgery can be associated with clinically signiﬁcant
morbidities. Iliac crest bone graft (ICBG) is considered by many to
be the gold standard for nonunion treatment, and a review on the
subject cited HRs as high as 87–100% [32]. However, ICBG is
associated with a high rate of donor site morbidity; among 170
patients, 24% reported harvest site numbness 3.5 years after
surgery, and 19% reported that harvest site pain resulted in
difﬁculty with routine chores [33]. Even without ICBG, surgery
introduces greater risk than LIPUS treatment, especially in
vulnerable patients [25]. In a recent study of 134 surgically
revised long-bone nonunions, complication rates from surgery
were reported to be 11% in patients who healed after one nonunion
procedure, 68% in patients who healed after multiple revisions, and
100% in patients who failed to heal [34].
If LIPUS offers a HR comparable to surgery, with fewer
associated morbidities, why is LIPUS not considered the gold
standard for treatment of chronic nonunion? This is a complex
question, but the simplest answer is that there are no RCTs that
directly compare LIPUS to modern surgical techniques for
nonunion [35]. In the absence of such trials, clinicians should be
reluctant to recommend LIPUS over the proven beneﬁts of
nonunion surgery. However, the National Institute for Health
and Care Excellence (NICE) in the United Kingdom evaluated the
evidence supporting LIPUS to promote healing of fracture nonunion
[35]. NICE concluded that ‘‘clinical evidence supports the use of
[LIPUS] in non-union long bone fractures. . . which have not healed
after 9 months.’’ LIPUS use in such cases was calculated to result in a
cost savings of $1726 per patient, due to avoidance of surgery [35].
A more recent study concluded that patients who received
nonunion surgery had total medical costs that averaged $6289
higher than patients who received LIPUS only [36]. LIPUS-only
treatment of nonunion was projected to result in a cost savings of
$4 billion annually in the United States [36]. NICE concluded that
‘‘successful use of [LIPUS] may eliminate the need for surgery and
its associated complications’’ [35]. This suggests an urgent need for
a direct comparison of LIPUS to surgery for fracture nonunion.
An inherent limitation of registry studies is the lack of untreated
controls and the absence of blinding; both patients and physicians
are aware of the type of treatment. Nevertheless, the absence of
controls in the current study must be placed in context: surgery had
already been attempted an average of 3.1 times prior to the start of
LIPUS treatment and patients probably did not anticipate success
with LIPUS (Table 3). We also note that RCTs are problematic in
the study of established nonunion because the use of an untreated
or placebo control group is considered unethical for fractures
that will not heal without intervention [7,16].
Registries do have certain advantages, most notably in cohort
size. This cohort is perhaps the largest group of consistently
deﬁned chronic nonunion fractures in the literature. By contrast,
most case series are small, reporting a few dozen patients. In
addition, bias can be signiﬁcant in case series because they are
often written when a clinician notices something out of the
ordinary: a rare fracture; an unexpectedly high (or low) heal rate;
or an unanticipated side effect. Thus, case series are unusual by
nature. Retrospective analyses also tend to be smaller and prone to
bias (positive or negative), as most are based on records from a
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which a consecutive series of patients from multiple centres were
prescribed LIPUS to treat chronic nonunion. In addition, the registry
reports real-world outcomes on many different fractures treated by
many different physicians. Its results are applicable to a range of
fracture locations, patient populations, and clinical settings.
The pathophysiology of failed fracture healing remains
incompletely understood, and the current data offer few clues
for predicting treatment failures with LIPUS. The 13.8% of chronic
nonunion patients who did not heal with LIPUS differed in no
obvious way from patients who did heal (Table 3). One exception
was patient age, which showed a small but signiﬁcant correlation
with lower HR. However, given the 80% heal rate in 80-year-old
patients, the clinical signiﬁcance of this observation seems low.
Factors often linked to poor healing, such as medical comorbidities,
smoking, prior surgeries, and fracture age, did not predict
treatment failure here. Other studies on refractory nonunions
have noted that such patients often have undiagnosed endocrine or
metabolic disorders [37] and may have uncharacterized genotypic
risk factors [38]. It is possible that a large multivariate analysis of
patient risk factors might reveal why some patients are prone to
nonunion, and this work is currently underway.
Conclusions
LIPUS treatment was associated with a high rate of healing
(86.2%) in a registry cohort of 767 nonunion fractures that had
failed to heal for at least one year prior to treatment. The LIPUS heal
rate is comfortably within the range of heal rates reported after
surgical revision, suggesting that LIPUS treatment may provide
comparable beneﬁt to surgery. If outcomes are equivalent, safety
issues would favour LIPUS, which is non-invasive and has no
known contraindications. Thus, LIPUS therapy may represent an
effective, low-risk alternative to surgical revision in the setting of
impaired fracture healing.
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